Saturday 17 October 2026
Export MDXH’s income statement to Excel — free account
MDxHealth SA
MDXH Healthcare Diagnostics & Research
MDxHealth SA’s revenue for fiscal 2025 (year ended December 2025) was $107.9 million, up 19.8% from fiscal 2024. In the quarter to June 2026, revenue grew 12.0%, EPS fell 15.8%, free cash flow fell 200.2% and total debt rose 26.0%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
0.21
0.39
−65.00%
Follow MDXH
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 4 | 4 | — |
| (807.44%) | (2,401.75%) | 491.05% | 238.67% | ||
| (22.62%) | (21.61%) | (20.86%) | (27.38%) | ||
ROIC |
(24.54%) | (25.09%) | (30.97%) | (23.77%) | |
Return on Tangible Assets |
(282.31%) | (377.87%) | (113.57%) | (404.34%) | |
Average Days of Receivables |
66.71 | 49.04 | 46.53 | 47.46 | |
Free Cash Flow per Share |
(0.14) | (0.07) | (0.04) | (0.11) | |
Free Cash Flow |
(6.98) | (3.35) | (2.09) | (6.02) | |
Capital Expenditures |
(1.29) | (1.16) | (1.04) | (0.72) | |
| Other line items | |||||
Cash ROIC |
(6.36%) | (3.29%) | (1.65%) | (6.48%) | |
Accounts Receivable Turnover |
6.01 | 7.50 | 7.51 | 7.49 | |
Accounts Payable Turnover |
3.70 | 4.38 | 4.25 | 4.88 | |
Inventory Turnover |
7.00 | 7.56 | 7.79 | 8.37 | |
Average Days of Payables |
93.61 | 93.96 | 105.71 | 91.39 | |
Days of Inventory on Hand |
60.64 | 61.31 | 64.53 | 55.63 | |
Tax Rate |
0.01 | (0.04) | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
10.01% | 10.33% | 9.50% | 8.82% | |
Selling, General and Administrative Expense of Revenue |
65.77% | 64.17% | 67.08% | 68.80% | |
Share Based Compensation of Revenue |
2.19% | 2.02% | 2.13% | 2.01% | |
Interest Coverage |
(0.96) | (0.91) | (0.79) | (0.78) | |
Operating CF/Net income |
0.16 | 0.07 | 0.03 | 0.14 | |
Depreciation/Fixed assets |
1.65 | 1.90 | 2.07 | 2.63 | |
Capex/Depreciation |
(0.14) | (0.13) | (0.11) | (0.08) | |
Revenue per Share |
1.99 | 2.19 | 2.14 | 2.19 | |
Operating CF per Share |
(0.11) | (0.04) | (0.02) | (0.10) | |
Capex per Share |
(0.03) | (0.02) | (0.02) | (0.01) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates